Efficacy of Daily vs Weekly Levothyroxine for Hypothyroidism
Researchers examined the safety and efficacy of daily vs weekly levothyroxine therapy for hypothyroidism in young and middle aged adults.
Researchers examined the safety and efficacy of daily vs weekly levothyroxine therapy for hypothyroidism in young and middle aged adults.
Synthroid was associated with an 11% lower likelihood of having out-of-range TSH lab values vs generic levothyroxine.
A 28-year-old male patient, otherwise in good health, presented with acute onset vertigo, nausea, and vomiting resulting from exogenous testosterone use.
Researchers noted a significant increase in serum vitamin D and significant reductions in TSH following 3 months of vitamin D supplementation.
Patients on HAART may require additional metabolic monitoring for cardiovascular issues.
A patient presented with intentional 10-pound weight loss, suppressed thyroid-stimulating hormone, and increased FT4 and TT3 levels.
The combined treatment regimen of metformin and liraglutide led to complete remission in 74% of patients with new onset type 2 diabetes.
More patients receiving empagliflozin and linagliptin combination therapy were able to reach HbA1c goals compared with those patients receiving monotherapy.
Patients with HIV and abdominal fat who received tesamorelin experienced positive changes in fasting blood glucose and glycated hemoglobin A1c.
Physicians need to be aware of silent thyroiditis as a rare but serious side effect of lithium therapy.